It was reported that a patient underwent a cardiac ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter and the patient experienced diaphragmatic nerve palsy.During ablation of the superior vena cava (svc), the diaphragmatic nerve was confirmed and no abnormality was found.A few days later, the patient was diagnosed with diaphragmatic nerve palsy.Physician's judgment on health hazard is non-serious (moderate/minor).The physician's opinions on the relationship between the event and the product is that mapping was performed and the procedure was performed with care not to ablate around the diaphragmatic nerve.No particular defects were observed in the bwi product.No abnormalities were observed prior to or during the use of the product.
|
Device investigation details: available information received indicates that the device is not available for return, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation (mre) cannot be conducted because no lot number was provided by the customer.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.E1.Initial reporter phone: (b)(6) if additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.(b)(4).
|
On 10-nov-2023, additional information was received indicating the physician commented that it was an accidental event, not caused by the product.No additional intervention was provided, and the patient was reported to have fully recovered.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.#(b)(4).
|